XWELL, Inc. (XWEL) · Oct 7, 2026 · Material agreement
Stock repurchase agreement
XWELL’s stock repurchase filing executes a previously disclosed XpresTest transaction, but provides no price or material new operating information.
XWELL is in the middle of divesting its XpresSpa and XpresTest businesses for $13 million, so this filing sits inside an already disclosed separation rather than a new strategic pivot.
This is closing paperwork, not a fresh business development. The side letter confirms the parties’ intent to complete the previously dated repurchase arrangement effective October 7, 2026: “in order to effectuate the parties’ mutual desire to consummate the transactions contemplated by the Stock Repurchase Agreement effective as of the date hereof.” 〔0〕
The filing adds no usable economics in the supplied excerpt. It does not state the repurchase price, share count, or any change to XWELL’s operating outlook, making the disclosure mainly documentary. The parties “acknowledge, confirm and agree for all purposes under the Stock Repurchase Agreement as follows:” 〔1〕
Bottom line: This advances an already announced XpresTest-related transaction but barely changes the underlying business story. Its significance is confirmation, not surprise or new operating information.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!